Shanghai-based Junshi Biosciences develops and globally markets biopharmaceuticals, including small molecule drugs.
Shanghai Junshi Biosciences Co., Ltd., founded in Shanghai, China, is a biopharmaceutical company dedicated to the development and commercialization of innovative drugs. The company's core mission is to improve global health through cutting-edge research and development of small molecule drugs, antibody drug conjugates, and other therapeutic products. Junshi Biosciences focuses on addressing unmet medical needs and enhancing patient outcomes worldwide.
Notable figures associated with Junshi Biosciences include leading scientists and industry experts who drive the company's research initiatives. The company has attracted significant investment from prominent venture capital firms, bolstering its R&D capabilities. Key achievements include the successful development and market introduction of several groundbreaking therapies, contributing to its reputation as a leader in the biopharmaceutical industry. Junshi Biosciences' impact is evident in its contribution to advancing medical science and improving patient care on a global scale.

Zai Lab
zailaboratory.com

Innovent Biologics

WuXi Biologics
wuxibiologics.com

Sino Biopharmaceutical

Brii Biosciences
briibio.com

Livzon Mabpharm

Artizan Biosciences

ShangPharma

Biocon
biocon.com

BeOne Medicines
beigene.com

Janssen Biotech

Rjs Biologics

Shanghai Kehua Bio-Engineering Co.

BridGene Biosciences

Sinogen Biopharma
Companies similar to Shanghai Junshi Biosciences Co include Zai Lab, Innovent Biologics, WuXi Biologics and Sino Biopharmaceutical.
Shanghai Junshi Biosciences Co was founded in 2012.
Shanghai Junshi Biosciences Co's headquarters is located in Shanghai, Shanghai, CN.
Shanghai Junshi Biosciences Co has 2,772 employees as of Feb 12, 2024.